In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation level. Estrada RA, Maselli DJ. Ann Intern Med 2023 Nov 7. doi: 10.7326/J23-0084.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Estrada RA, Maselli DJ. In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation level. Ann Intern Med 2023 Nov 7. doi: 10.7326/J23-0084.
PMID: 37931261